| Health / Medical Topics |
Glycooptimized Trastuzumab-GEX
A glycoengineered form of a monoclonal antibody directed against the human epidermal growth factor receptor-2 (HER2), with potential antineoplastic activity. Glycooptimized trastuzumab-GEX specifically binds to the extracellular domain of HER2, thereby inducing an antibody-dependent cell-mediated cytotoxicity (ADCC) against HER2-expressing tumor cells. This eventually results in apoptosis and growth inhibition of tumor cells. HER2, a member of the receptor tyrosine kinase EGFR superfamily, is overexpressed on the cell surfaces of various solid tumors. This agent has a specific glycosylation profile that may enhance its ADCC response against HER2-expressing tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
The collective identity of the entirety of carbohydrates (glycans) in an organism.
Glycolysis is the process of converting glucose into pyruvate and generating small amounts of ATP (energy) and NADH (reducing power). It is…
In glycolysis, the six-carbon sugar glucose is oxidized and split in two halves, to create two molecules of pyruvate (3 carbons each)…
Glycolysis Inhibition involves interference with, or restraint of, the activities of the pathway by which glucose is catabolized into two molecules of…
Glycolysis Induction involves initiation of activities of the pathway by which glucose is catabolized into two molecules of pyruvic acid with the…
A process in which glucose (sugar) is partially broken down by cells in enzyme reactions that do not need oxygen. Glycolysis is…
